Browsing by Author "Swords, R"
Now showing items 1-3 of 3
-
Class effects of tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia
Giles, F J; O'Dwyer, M; Swords, R (Springer Nature, 2009-05-28)Tyrosine kinase inhibitors have revolutionized the treatment of chronic myeloid leukemia (CML), offering patients several targeted therapeutic options that provide the possibility of sustained remissions and prolonged ... -
Spurious elevation of the cerebrospinous fluid white cell counts in three patients receiving liposomal cytarabine as part of post-remission therapy
Swords, R; O'Rafferty, C; Giles, F; Browne, P (Springer Nature, 2008-06-05) -
Targeting the fms-like tyrosine kinase 3 in acute myeloid leukemia
Swords, R; Freeman, C; Giles, F (Springer Nature, 2012-04-27)Acute myeloid leukemia (AML) is a highly heterogenous disease with multiple signaling pathways contributing to its pathogenesis. A key driver of AML is the FMS-like tyrosine kinase receptor-3 (FLT3). Activating mutations ...